Despite pressures on the broader Indian pharmaceutical sector, laboratory stocks like Alkem Laboratories and Dr. Lal PathLabs are demonstrating strong recovery and bullish momentum. Technical indicators such as breakouts, strong moving average positions, and positive Relative Strength Index (RSI) suggest potential for upward movement. These companies are distinguishing themselves within the healthcare sub-sector, offering a potentially favorable outlook for investors.

Source: The Financial Express